<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               INDICATIONS AND USAGE<BR>               <BR>                  Mercaptopurine is indicated for maintenance therapy of acute lymphatic (lymphocytic, lymophoblastic) leukemia as part of a combination regimen. The response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric or adult). <BR>                  Mercaptopurine is not effective prophylaxis or treatment of central nervous system leukemia. <BR>                  Mercaptopurine is not effective in acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including Hodgkins Disease), or solid tumors. <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>